The current financial score of Celcuity Inc is 6.30. Its financial status is stable, and its operating efficiency is low.
The current valuation score of Celcuity Inc is 9.33. Its current P/E ratio is -20.68, which is -86.98% below the recent high of -2.69 and -85.12% above the recent low of -38.29.
The current earnings forecast score of Celcuity Inc is 8.83. The average price target is 161.09, with a high of 177.00 and a low of 140.00.
The current price momentum score of Celcuity Inc is 4.54. Currently, the stock price is trading between the resistance level at 92.41 and the support level at 74.41, making it suitable for range-bound swing trading.
The current institutional shareholding score of Celcuity Inc is 10.00. The latest institutional shareholding proportion is 97.67%, representing a quarter-over-quarter increase of 12.26%.
No risk assessment score is currently available for Celcuity Inc. The Biotechnology & Medical Research industry's average is 3.98. The company's beta value is 0.10. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.